Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Mohammed MN Abozaid Author

Subjects of specialization
Mucoepidermoid carcinoma, Cancer chemotherapy, Prostate biomarker

Affiliation
Department of Chest, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Biography

Mohammed MN Abozaid was working in the Department of Chest, Faculty of Medicine, Zagazig University, Zagazig, Egypt. He has more than 40 publications. His current research area related to osteoarthropathy. 


Publications

Research Article Subscription

Cripto-1 and RUNX2 Expressions in Non-small Cell Lung Cancer, their Roles in its Progression and Patients Outcome

Author(s):

Ola A Harb, Shereen El shorbagy, Nehal S Abouhashem, Ola M Elfarargy, Safa A Balata, Loay M gertallah, Mohammed MN Abozaid, Walid Galal and Sameh Saber

Background: Non-small cell carcinoma of lung (NSCLC) is the commonest and most lethal lung cancer type; it includes squamous cell carcinoma, adenocarcinoma, and large cell carcinoma subtypes. The five-year survival rate in NSCLC patients is still very low although improvements in treatment modalities are still emerging. Hence, new prognostic markers and therapies need to be brought to light aiming to improve patients' outcome. Cripto-1 (CR-1) is one of the family members of epidermal-growth-factor; cripto FRL1 cryptic-(EGF-CFC) is needed for embryogenesis. Runt-related-transcription-factor [RUNX] family members make core-binding factor complex (CBFC) that attach to DNA to stimulate or inhibit many genes transcription, regulate the survival, ... view moreĀ»

DOI: 10.4172/2324-9110.1000182

Abstract HTML PDF



Google Scholars / Researchers Sites

GET THE APP